rediff.com
e.g. Tata motors, Reliance MF, 500570
Bliss GVS Pharma Ltd. - Research Center
506197 BLISSGVS Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 605.46 598.34 636.36 465.51 441.95
Expenses
Material consumed 299.47 314.90 343.94 253.30 236.72
Manufacturing expenses 8.81 5.80 7.09 6.99 4.70
Personnel expenses 82.59 72.54 65.06 58.61 44.02
Selling expenses 0.99 0.50 0.14 0.17 0.56
Adminstrative expenses 106.43 114.45 110.92 54.98 55.78
Expenses capitalised - - - - -
Cost of sales 498.29 508.18 527.16 374.05 341.78
Operating profit 107.17 90.16 109.20 91.46 100.17
Other recurring income 33.50 50.77 32.63 17.68 37.00
Adjusted PBDIT 140.67 140.92 141.83 109.14 137.17
Financial expenses 5.81 10.06 4.32 4.19 6.62
Depreciation 23.52 15.17 13.85 13.76 8.83
Other write offs - - - - -
Adjusted PBT 111.34 115.69 123.66 91.19 121.71
Tax charges 19.61 30.21 33.74 23.69 29.38
Adjusted PAT 91.73 85.48 89.92 67.50 92.33
Non recurring items -41.24 -0.67 3.05 0.52 -0.26
Other non cash adjustments - - - - -
Reported net profit 50.49 84.81 92.97 68.02 92.08
Earnigs before appropriation 896.67 850.15 769.19 681.38 625.77
Equity dividend 5.21 5.19 5.18 5.16 12.41
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 891.46 844.96 764.02 676.22 613.36
Close
Add Bliss GVS Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bliss GVS Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close